Hikma Pharmaceutical | HIK - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Almirall EUR 303.77M 21.04M 2026-06
argenx SE USD 36M 432K 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Autolus Therapeutics Ltd USD 277.27M 7.07M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Fresenius EUR 9.55B 1.24B 2026-06
Genmab DKK 4.96B 28M 2026-06
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 7.17B 1.91B 2026-06
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Orion EUR 103.4M 7.2M 2026-06
Recordati EUR 1.69B 67.09M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 14.65B 806M 2026-06
UCB EUR 2.18B 634M 2025-12